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Clonal Acquisition of Inhibitory Ly49 Receptors
on Developing NK Cells Is Successively Restricted
and Regulated by Stromal Class I MHC
splenic NK1.11CD32 cells, which did or did not express
various Ly49 receptors, were transferred into sublethally
irradiated mice. After 10 days, a fraction of the
NK1.11CD32Ly49A2C2G22I2 donor cells had initiated
expression of Ly49G2 or Ly49C/I. Initiation of Ly49G2 or
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Ly49C/I expression was also observed with transferredBerkeley, California 94720
Ly49A1C2G22I2 NK cells. The transferred Ly49A1 cells
maintained expression of Ly49A, suggesting that ex-
pression, once it occurs, is quite stable. It was con-Summary
cluded that NK cells expressing one Ly49 receptor could
go on to express others in a cumulative fashion.We report an in vitro stroma-dependent system for
The finding that Ly49 receptors are expressed in athe clonal growth and differentiation of natural killer
cumulative and successive fashion by developing NK(NK) cells from lymphoid-restricted bone marrow pro-
cells fulfills a prediction of the ªsequential expressiongenitors or bone marrow NK1.11 cells. Strikingly, the
modelº of NK cell development. This model proposed
potential to initiate expression of specific Ly49 recep-
that the successive accumulation of different Ly49 re-
tors becomes increasingly restricted as NK cells de-
ceptors by developing NK cells is terminated once the
velop. Moreover, when NK cells express a Ly49 recep-
cell expresses receptors with sufficient avidity for self
tor specific for stromal cell class I MHC, they are less
MHC class I molecules (Held and Raulet, 1997; Raulet
likely to initiate expression of another Ly49 receptor in et al., 1997). Independent evidence shows that the reper-
the clonal culture system. The results indicate multiple toire of inhibitory receptors expressed by NK cells is
roles for stromal cells in NK cell development, in sup- influenced by the MHC class I alleles expressed in an
porting clonal growth, in initiation of Ly49 receptor animal. Specifically, NK cells expressing multiple Ly49
expression, and in formation of the NK cell receptor receptors specific for an MHC ligand are less frequent
repertoire. in mice that contain the ligand than in mice that do not.
For example, Ly49A1G21 double-positive NK cells were
Introduction 2- to 4-fold less abundant in H-2d mice, which express
strong ligands for these receptors, than in H-2b or b2m2/2
Natural killer (NK) cells lyse a variety of target cells with- mice, which do not (Held and Raulet, 1997; Hoglund et
al., 1997; Raulet et al., 1997). Moreover, in mice express-out prior immunization (Trinchieri, 1989). Self MHC class
ing a transgenically encoded Ly49A receptor expressedI molecules expressed by target cells can inhibit NK cell
in all NK cells, the frequency of NK cells expressingattack. Consequently, NK cells are prevented from killing
the endogenous Ly49G2 receptor was reduced by 2- tonormal self cells but can attack self cells that have extin-
3-fold in H-2d mice compared to H-2b and b2m2/2 miceguished expression of class I MHC molecules as a con-
(Held and Raulet, 1997; Raulet et al., 1997). We proposedsequence of infection, mutation, or transformation (Ljung-
that engagement of Ly49A by Dd inhibited developinggren and Karre, 1990). In the mouse, receptors for class
NK cells from initiating expression of other receptors.I include the CD94/NKG2 and Ly49 receptor families.
By limiting the number of self MHC±specific receptorsAt least nine closely related Ly49 receptors have been
that NK cells express, such a mechanism would endowidentified (Ly49A-I), which are encoded within the NK
NK cells with a greater capacity to discriminate bodycomplex on mouse chromosome 6 (Yokoyama, 1995;
cells that extinguish expression of some, but not all, selfBrown et al., 1997; McQueen et al., 1998). Ly49 receptors
class I MHC proteins (Raulet et al., 1997).are expressed on overlapping subsets of NK cells such
The question arises whether the sequence in whichthat a single NK cell may express several receptors
Ly49 receptors are expressed by NK cells is random or,(reviewed in Raulet et al., 1997; Kubota et al., 1999).
alternatively, is ordered in some way. An ordered patternMost of the Ly49 receptors have been shown to exhibit
of receptor expression could impact the final repertoirespecificity for different class I alleles, with each binding
considerably. The possibility that the process is at leastone or more of the MHC class Ia molecules tested (Dan-
partly ordered was suggested by the finding that whileiels et al., 1994; Takei et al., 1997; Hanke et al., 1999).
transferred NK1.11Ly49G2/C/I2 splenocytes clearly ini-Evidence suggests that differentiating NK cells tra-
tiated expression of Ly49G2 and/or Ly49C/I, transferredverse a developmental stage in which expression of
NK1.11Ly49A2 splenocytes never initiated expressionLy49 receptors is initiated in a successive and cumula-
of Ly49A (Dorfman and Raulet, 1998). As one possibilitytive fashion (Dorfman and Raulet, 1998). Highly purified
to explain this discrepancy, we proposed that commit-
ment to initiate Ly49A expression is limited to an early
* To whom correspondence should be addressed (e-mail: raulet@ stage of NK cell development, before expression of
uclink4.berkeley.edu). NK1.1 or before NK cells migrate from the bone marrow² Present address: Department of Immunology, Institut Pasteur, 25
to the spleen. In this model, initiation of Ly49G2 orrue du Dr. Roux, 75724 Paris Cedex 15, France.
Ly49C/I expression occurs at a later stage, after NK1.1³ Present address: Department of Advanced Pharmacology, Otsuka
is expressed.Pharmaceutical Co., Ltd., 463-10 Kagasuno, Tokushima, Kawauchi-
cho, 771-0192, Japan. The signals that induce Ly49 expression in developing
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NK cells are poorly characterized. Complete NK cell
development in mice requires interactions between
committed NK progenitors and the bone marrow micro-
environment (Hackett et al., 1986; reviewed in Raulet,
1999). Among the signals produced by bone marrow
stromal cells, IL-15 and its receptor were recently shown
to play an important role in NK cell maturation both in
the human and murine systems (MroÂ zek et al., 1996;
Jaleco et al., 1997; Williams et al., 1997; Lodolce et al.,
1998). Indeed, IL-15 was shown to induce human NK
cells to express CD94/NKG2 receptors (Mingari et al.,
1997). However, while development of murine NK cells
from progenitor cells in vitro was stimulated by IL-15 in
concert with other cytokines, initiation of Ly49 expres-
sion did not occur (Williams et al., 1997). Nor did IL-15
efficiently induce the expression of the human KIR family
of inhibitory receptors on human NK cells (Mingari et
al., 1997). These data suggested that additional stromal
signals or cytokines are necessary to induce Ly49 recep-
tor expression by developing NK cells.
To investigate the process of receptor expression dur-
ing development of murine NK cells, we have developed
a system in which murine NK cells or earlier precursor
cells can be efficiently cloned. This was accomplished
with a modification of the NK long-term bone marrow
culture system, in which precursors are cultured in the
presence of cytokines and a bone marrow stromal layer
(van den Brink et al., 1990; Delfino et al., 1996). Using
this system, we demonstrate that the induction of Ly49
receptors on developing NK cells in vitro requires signals
Figure 1. Clonal Growth of Sorted Bone Marrow±Derived Cell Popu-
from bone marrow stromal cells and that Ly49 receptor lations Employed for Analysis of NK Cell Development
expression by developing NK cells occurs successively Percoll gradient purified bone marrow cells were further purified by
and cumulatively. The data suggest that NK cell devel- cell sorting for the indicated markers and cultured at limiting dilution
opment is characterized by successive restrictions in in the presence of stromal cells and cytokines.
(A) Gates for three-color sorting of NK1.11CD32CD192Ly49A/C/F/the capacity to initiate expression of different Ly49 re-
G2/I2 cells that express DX5 are shown (left panels). Reanalysisceptors. Importantly, we also show that stromal class I
of the sorted NK1.11DX51CD32CD192Ly49A/C/F/G2/I2 populationMHC expression influences the cumulative acquisition
revealed a 91% pure population (right panels).
of Ly49 receptors during NK cell differentiation. (B) Gates for three-color sorting of c-kit1Sca-21 cells that are also
negative for lineage markers, including NK1.1, are shown (left pan-
els). Reanalysis of the sorted c-kit1Sca-21Lin2 population revealedResults
a 91%±93% pure population (right panels).
(C) Clonal growth of sorted NK1.11DX51Ly49A/C/F/G2/I2 andA Short-Term Clonogenic Assay for Analysis
c-kit1Sca-21Lin2 precursor cells. Both populations were cultured
of NK Cell Development at limiting dilution with either irradiated B6 bone marrow stromal
To examine the initiation of expression of Ly49 receptors cells (closed circles) or irradiated OP9 stromal cells (open circles)
in developing NK cells, we devised an in vitro system in the presence of c-kit ligand, IL-7, flt-3 ligand, and IL-15. The
number of growing wells containing NK1.11 cells was determined.in which bone marrow precursor cells, lacking expres-
The frequency of wells that did not contain growing NK1.11 cells atsion of various Ly49 receptors, could be cloned in tissue
day 10 is plotted against the number of input cells. Results areculture. Two bone marrow populations were compared:
representative of three independent experiments each.
a population with an NK phenotype (NK1.11DX51
CD32CD192), which had been depleted of cells express-
ing Ly49A, Ly49C, Ly49F, Ly49G2, and Ly49I (hereafter stroma were established by culturing either syngeneic
(B6) or MHC-different (B10.D2; B6-b2m2/2) bone marrowcalled NK1.11DX51Ly492 cells for convenience), and
a population defined as a less committed, lymphoid- cells or the OP9 stromal cell line (Kodama et al., 1994)
in the wells. These culture conditions are similar to thoserestricted progenitor cell (c-kit1 Sca-21 Lineage marker2
[Lin2]) (Antica et al., 1994; Williams et al., 1997). The used previously to support the proliferation of NK pre-
cursor cells in ªNK-long-term bone marrow culturesºlineage markers included CD3, CD19, Gr-1, TER-119,
Mac-1, and NK1.1. Typical sorting parameters of both (NK-LTBMC) (Delfino et al., 1996). Strikingly, the
NK1.11DX51Ly492 cells yielded growing clones at a sur-populations are shown in Figures 1A and 1B. Post-sort
analyses indicated that the sorted populations were prisingly high efficiency, approximately one in three (Fig-
ure 1C). The c-kit1Sca-21Lin2 population yielded clonesgreater than 89%±93% pure, with most of the contami-
nants being non-NK cells (Figures 1A and 1B). with a lower efficiency, approximately 1 in 55. In both
cases, the clones grew for up to 4 weeks, yielding colo-The sorted populations were cultured at limiting dilu-
tion in wells containing irradiated stromal cells and cyto- nies of up to 1 3 105 cells, but eventually ceased grow-
ing, even if transplanted onto wells containing newkines (c-kit ligand, IL-7, flt-3 ligand, and IL-15). The
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Table 1. Expression of Ly49 Receptors by Colonies Derived from NK1.11DX51Ly49-Depleted Bone Marrow Cells under Limiting
Dilution Conditions
Fraction of Ly491 Wellsd
Number of Ly5.1/5.2
Input Cells Cells per Well Growing Wellsa Wells Testedb Mixed Wellsc A F G2 C/I
NK1.11DX51Ly492 4 32/48 26 5/26 0/26 0/26 7/26 11/26
(Ly5.1/5.2 mix); 2 22/48 13 2/13 0/13 0/13 3/13 4/13
Bone marrow stroma 1 48/192 32 2/32 0/32 1/32 6/32 19/32
0.5 29/192 21 0/21 0/21 0/21 2/21 10/21
Total 92 0/92 1/92 18/92 44/92
(0%) (1%) (20%) (48%)
NK1.11DX51Ly492; 2 46/96 23 NTe 0/23 0/23 2/23 12/23
OP9 stroma 1 28/96 15 NT 0/15 0/15 1/15 7/15
Total 38 0/38 0/38 3/38 19/38
(0%) (0%) (8%) (50%)
The indicated input cells were cultured for at least 10 days with cytokines and the indicated stroma and resulting colonies examined by flow
cytometry for expression of NK1.1, Ly5.1/5.2 and Ly49A, Ly49F, Ly49G2, and Ly49C/I.
a Fraction of wells with visible colonies.
b The number of wells tested by flow cytometry.
c The fraction of wells containing both Ly5.11 and Ly5.21 cells.
d The fraction of wells containing $5% of cells expressing the indicated Ly49 receptor.
e Not tested.
stroma and cytokines (data not shown). Similar results the colony by two-color staining (data not shown). The
remaining 24% of colonies contained only CD191 cells.were obtained in two other experiments. The cloning
efficiency was similar whether bone marrow cells or OP9 Data indicated that most, if not all, of the mixed colonies
were derived from single progenitor cells. First, thecells were employed to generate the stroma (Figure 1C).
In comparable cultures lacking stroma, no clones were mixed NK1.11/CD191 colonies were as frequent at the
lowest input cell number (4/well) as at the highest (Tablegenerated from either progenitor cell population using
relatively high numbers of input cells (4 NK1.11DX51 2). Second, when the input cells consisted of a 1:1 mix
of Ly5.11 and Ly5.21 cells, none of the mixed NK1.11/Ly492 or 32 c-kit1Sca-21Lin2 cells/well; data not
shown). Preliminary functional tests showed that at least CD191 colonies obtained at low input cell numbers were
mixed with respect to Ly5 expression (Table 2, experi-some of the clones exhibit cytotoxicity specific for the
NK-sensitive YAC-1 target cells (data not shown). The ment 2). The results demonstrate that under these cul-
ture conditions, a single uncommitted c-kit1Sca-21Lin2small burst size of NK clones differentiating under these
conditions (#1 3 105 cells) precluded a systematic anal- progenitor cell can divide, yielding daughter cells that
subsequently differentiate into either NK lineage or Bysis of class I inhibition of the clones.
A variety of evidence indicated that the colonies ob- lineage cells.
tained with both types of precursor cells were clonal in
origin. First, both precursor cell populations yielded a Initiation of Ly49 Receptor Expression by Developing
NK Cells in the Clonogenic Culture Systemlinear relationship between the input cell number and
the log of the fraction of nongrowing wells, consistent Expression of Ly49A, F, G2, and C/I by the clones was
determined. Significantly, an appreciable fraction ofwith clonal growth. As a further test of clonality, we
initiated cultures with limiting numbers of cells from a clones derived from NK1.11DX51Ly492 precursors con-
tained cells expressing Ly49G2 or Ly49C/I (Table 1).1:1 mixture of precursor cells obtained from B6-Ly5.1
and B6-Ly5.2 mice. The experiment was carried out with Staining profiles for representative clones obtained with
a low cell input number (0.5±1 cell/well) are shown ineither NK1.11DX51Ly492 (Table 1) or c-kit1Sca-21Lin2
(Table 2) cells as precursors. In both cases, essentially Figure 2A. Expression of Ly49G2 and Ly49C/I was al-
most always heterogeneous, with some of the cells inall of the growing wells obtained at low cell inputs con-
tained cells expressing either Ly5.1 or Ly5.2 but not the well positive and some negative for a given receptor.
Some of the clones contained both Ly49C/I1 andboth, as expected for clonal conditions (Tables 1 and 2).
Individual clones were tested for expression of various Ly49G21 cells, mostly on separate subpopulations,
though coexpression may occur on a small subset inmarkers. All of the clones derived from the NK1.11DX51
Ly492 population homogeneously expressed NK1.1 some of the clones (e.g., B12 and B1). Therefore, while
the colonies were clonal in origin, they were not homoge-(Figure 2A) and were CD32 (data not shown), identifying
them as NK cells. In contrast, the c-kit1Sca-21Lin2 pop- neous in Ly49 expression.
Strikingly, while many NK1.11DX51Ly492 precursorulation yielded both NK lineage and CD191 (B lineage)
cells (Table 2, experiment 2). An average of 76% of the cells initiated expression of Ly49G2 and/or Ly49C/I ex-
pression in culture, none initiated expression of Ly49Agrowing wells contained NK1.11CD32 cells. About half
of these colonies also contained CD191 cells, which and only one initiated expression of Ly49F. Thus,
NK1.11DX51Ly492 precursor cells differentiating in vitrowere shown to represent a separate population within
Immunity
146
Figure 2. Ly49 Expression by Clones Derived In Vitro from NK1.11DX51Ly49A/C/F/G2/I2 or c-kit1Sca-21Lin2 Precursor Cells
(A) Representative clones derived from NK1.11DX51Ly49A/C/F/G2/I2 precursor cells, derived at 1 input cell per well (clones F3, D2, and B1)
or 0.5 cell per well (clones F5, B12, H3) are shown. Percentages are indicated in the quadrants.
(B) Representative clones derived from c-kit1Sca-21Lin2 precursor cells, derived at 32 input cells/well (clones F6, H1, H5, H6), 16 cells/well
(clones C3, G8), or 8 cells/well (clone A8) are shown. For H1 and H5 clones, double staining with anti-Ly49G2 and anti-Ly49C/I is shown on
gated NK1.11 cells. Some clones contained a CD191 population. Percentages correspond to percent of NK1.11 cells in the colonies.
exhibit potential to initiate expression of Ly49G2 and cells from Ly5.2 mice in a cloning experiment, Ly5.21
clones represented 5%±20% of the total, as would beLy49C/I, but little or no potential to express Ly49A or
Ly49F. predicted if the two populations exhibited similar cloning
efficiency (data not shown). Taken together, the dataThe possibility that the Ly491 clones were derived
from Ly491 contaminants in the input cell population is demonstrate that clonogenic NK1.11DX51Ly492 precur-
sor cells give rise to colonies containing Ly49C/I1 orhighly unlikely. Since Ly49 expression, once initiated,
appears to be quite stable (Dorfman and Raulet, 1998; Ly49G21 NK cells in vitro.
see below), colonies derived from Ly491 contaminants
would not be expected to be heterogeneous for Ly49 Developing c-kit1Sca-21Lin2 Progenitor Cells
Can Initiate Ly49A Expression In Vitroexpression, in contrast with the data (Figure 2A). Further-
more, the NK1.11 input cells were essentially devoid of The finding that NK1.11DX51Ly492 precursor cells give
rise to clones expressing Ly49G2 or Ly49C, but notLy49A/C/F/G2/I1 cells as assessed by post-sort analy-
sis. In addition, semiquantitative RT-PCR analysis indi- Ly49A, is consistent with the results of our earlier study,
which showed that splenic NK1.11Ly49A/C/G2/I2 cells,cated that the extent of contamination of the input cells
by cells expressing one or the other Ly49 receptor was after transfer in vivo to irradiated recipient mice, gave
rise to Ly49G21 and Ly49C/I1 NK cells but not to Ly49A1always less than 5%, and often less than 0.5% (data
not shown). Even if the cloning efficiency of Ly491 cells cells. One possible explanation for these data is that
commitment to expression of Ly49A occurs at an earlywas greater than that of Ly492 cells, the high overall
cloning efficiency we observed (approximately 30%) is stage in development, perhaps even before expression
of NK1.1. This model predicts that less restricted pro-incompatible with the possibility that the Ly491 colonies
arose from contaminants. Moreover, direct comparisons genitor cells, at a stage prior to NK1.1 expression,
should give rise to Ly49A1 clones in vitro. The analysisindicated that the cloning efficiency of purified Ly491
cells is no higher than that of Ly492 cells (see below; of NK1.11 clones derived from c-kit1Sca-21Lin2 progen-
itors verified this prediction. Among the colonies ob-Table 3). As a further indication of this point, when we
employed 1:10 cell mixtures of NK1.11Ly492 cells from tained with these cells, we detected NK cells expressing
each of the four Ly49 receptors tested, including Ly49ALy5.1 mice and NK1.11Ly491 (Ly49G21 or Ly49C/I1)
Regulation of Ly49 Expression on NK Precursors
147
Table 2. Expression of Ly49 Receptors and Markers by Colonies Derived from c-kit1Sca-21Lin2 Precursor Cells at Limiting Dilution
Fraction of Ly491 Wellsf
Cells Growing CD191 NK1.11 NK1.11/CD191 Ly5.1/5.2
Input Cells per Well Wellsa Wellsb Wellsc Wellsd Mixed Wellse A F G2 C/I
c-kit1Sca-21Lin2 32 42/96 NTg 34/42 NT NT 5/14 0/14 9/14 3/14
(NK1.12); 16 35/96 NT 24/35 NT NT 0/7 0/7 3/7 2/7
Bone marrow 8 16/96 NT 12/16 NT NT 1/2 0/2 1/2 1/2
Stroma 4 7/96 NT 4/7 NT NT 1/1 0/1 1/1 1/1
Totals 74/100 7/24 0/24 14/24 7/24
(74%) (29%) (0%) (58%) (29%)
c-kit1Sca-21Lin2 64 83/96 58/83 66/83 41/83 3/15 2/13 0/13 5/13 5/13
(NK1.12Ly492) 32 57/96 30/57 46/57 19/57 3/22 7/20 2/20 13/20 7/20
(Ly5.1/5.2 mix); 16 49/96 31/49 32/49 14/49 1/22 5/20 1/20 11/20 6/20
OP9 stroma 8 27/96 18/27 20/27 11/27 1/7 1/4 0/4 2/4 1/4
4 15/96 9/15 12/15 6/15 0/7 1/7 0/7 4/7 1/7
Totals 146/231 176/231 91/231 16/64 3/64 35/64 20/64
(63%) (76%) (39%) (25%) (4%) (54%) (31%)
The indicated input cells were cultured for at least 10 days with the indicated stroma and resulting colonies examined by flow cytometry for
expression of CD19, NK1.1, Ly5.1/5.2, Ly49A, Ly49F, Ly49G2, and Ly49C/I.
a Wells with visible colonies/wells plated.
b Wells containing CD191 cells/growing wells.
c Wells containing NK1.11 cells/growing wells.
d Wells containing both NK1.11 and CD191 cells/growing wells.
e Wells containing both Ly5.11 and Ly5.21 cells/wells tested.
f Wells containing $5% of cells expressing the indicated Ly49 receptor/wells tested.
g Not tested.
and Ly49F (Table 2; Figure 2B). Comparable Ly49 ex- with only a fraction of the NK1.11 cells in each well
expressing any given receptor (Figure 2B). In addition,pression was observed in colonies containing only NK
cells and colonies containing both NK cells and CD191 we also observed clones in which two or three Ly49
receptors were expressed by cells in the population. Incells, indicating that the culture conditions support initi-
ation of Ly49 expression on NK cells as they differentiate most such cases, expression of different Ly49 receptors
within a colony was predominantly nonoverlapping,from relatively undifferentiated progenitor cells. Al-
though c-kit1Sca-21Lin2 cells do not express Ly49 re- though some overlap was observed (e.g., clones H1 and
H5). In rare cases, extensive overlap was observed, asceptors (data not shown), antibodies against Ly49A/C/
F/G2/I were included in the cocktail of lineage-specific in clone C3 where nearly all the cells coexpressed Ly49A
and Ly49G2 (Figure 2B).antibodies in some sorting experiments (e.g., Table 2,
experiment 2). The frequencies of clones expressing
each Ly49 receptor was 25%±29% for Ly49A, 0%±4% Successive and Restricted Potential for Ly49
Expression by Developing NK Cellsfor Ly49F, 54%±58% for Ly49G2, and 29%±31% for
Ly49C/I. As seen with the NK1.11 precursor cells, most We next investigated whether cells that express one
of the Ly49 receptors can initiate expression of otherof the clones were heterogeneous in Ly49 expression,
Table 3. Initiation of Additional Ly49 Expression by NK1.11 Cells Expressing Ly49A and Ly49G2 Cultured at Limiting Dilution
Fraction of Ly491 Wellsc
Cells Number of
Input Cells per Well Growing Wellsa Wells testedb A F G2 C/I
NK1.11Ly49A1 Exp. #1 1 33/96 16 15/16 8/16 2/16 8/16
(Ly49F/G2/C/I)2 (93.7%) (50%) (12%) (50%)
Exp. #2 1 70/288 28 24/28 15/28 5/28 15/28
(85%) (53%) (17%) (53%)
NK1.11Ly49G21 Exp. #1 1 29/96 14 0/14 0/14 14/14 3/14
(Ly49A/F/C/I)2 (0%) (0%) (100%) (21%)
Exp. #2 1 90/288 78 0/78 0/78 78/78 22/78
(0%) (0%) (100%) (28%)
The indicated input cells were cultured for at least 10 days with OP9 stromal cells and cytokines and the resulting colonies examined by flow
cytometry for expression of NK1.1 and Ly49A, Ly49F, Ly49G2, and Ly49C/I.
a Wells with visible colonies.
b The number of wells tested by flow cytometry.
c The number of wells containing $5% of cells expressing the indicated Ly49 receptor.
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Uncommitted c-kit1Sca-21Lin2 precursors were used
because they are immature cells and exhibit the po-
tential to generate a diverse repertoire. Accordingly,
Ly49Atgc-kit1Sca-21Lin2 precursors were sorted and
cloned onto irradiated bone marrow stromal cells de-
rived from B10.D2 (H-2d), B6 (H-2b), and class I±deficient
(b2m2/2) mice. In addition, to reveal any effects of class
I MHC expression by the growing NK cells themselves,
MHC-congenic precursors were used that either did or
did not express H-2Dd, a known high-affinity ligand for
the transgenic Ly49A receptor (Ly49AtgB10.D2 or
Ly49Atgb2m2/2 precursors, respectively). Precursor cells
were seeded at 30 cells/well. The resulting cloning effi-
ciencies were similar for all conditions.
Each clone was examined for the percentage of NK
cells that expressed Ly49G2 (Figures 4A and 4B). In
the case of Ly49Atgb2m2/2 precursors, the percentagesFigure 3. Sorted Ly491 Bone Marrow Cell Populations Employed
varied considerably among the clones from each group,for Analysis of NK Cell Development
but the average percentage of Ly49G21 NK cells was(A) CD32CD192NK1.11 B6-derived bone marrow cells were sorted
significantly higher on stromal cells that lacked MHCfor the expression of Ly49A, but not Ly49F, G2, C/I. Post-sort analy-
sis indicated a purity of 92%. expression (b2m2/2 stroma; Figure 4A, 34% 6 5%) than
(B) CD32CD192NK1.11 B6-derived bone marrow cells were sorted on stroma that expressed a strong MHC ligand for the
for the expression of Ly49G2, but not Ly49A, F, C/I. Post-sort analy- transgenic receptor (B10.D2 stroma; Figure 4A, 8% 6
sis indicated a purity of 95%±98%. 2%). Interestingly, the percentage of Ly49G21 NK cells
on H-2b stromal cells (17% 6 4%), a haplotype not
known to interact strongly with either Ly49 receptorreceptors in the clonogenic assay. NK1.11CD32CD192
(Daniels et al., 1994; Takei et al., 1997; Hanke et al.,cells that express Ly49A, but not Ly49C/F/G2/I, were
1999), was significantly lower than that observed withsorted from the bone marrow to high purity (Figure 3A)
b2m2/2 stroma. Notably, the effects of the stromal cellsand subsequently cloned at 1 cell/well. The cloning effi-
were similar if the precursor cells themselves expressedciency averaged 29% (Table 3), similar to that of
endogenous H-2Dd ligand for the transgenic Ly49A re-NK1.11DX51Ly492 NK cells. When tested after at least
ceptor (Ly49AtgB10.D2 precursors; Figure 4B). In this10 days of culture, an average of 90% of the clones
case, due primarily to the analysis of fewer clones, onlyhomogeneously expressed Ly49A, consistent with the
the results comparing b2m2/2 and H-2d stromal cellspurity of the input cells (Table 3; Figure 3A; data not
scored as a statistically significant difference. Neverthe-shown). Therefore, Ly49A expression, once initiated, is
less, the similarity of the trend demonstrates that the
quite stable. Significantly, a fraction of the clones had
MHC haplotype of the bone marrow stromal cells plays
initiated expression of each of the other Ly49 receptors
a predominant role in determining Ly49 receptor expres-
tested, including Ly49F (52%), Ly49G2 (16%), and
sion during NK cell differentiation in vitro.
Ly49C/I (52%) (Table 3). Thus, Ly49A1C/F/G2/I2 NK cells Similar trends were observed when we plotted the
from the bone marrow exhibit the potential to subse- frequency of clones containing few or no (#5%)
quently initiate expression of Ly49F, Ly49G2, and Ly49G21 NK cells (threshold indicated by dotted line in
Ly49C/I in vitro. Figures 4A and 4B). None of the clones that developed
To extend the analysis, Ly49G21A/C/F/I2 NK cells on b2m2/2 stroma met this criterion (Figure 4C), sug-
were sorted to high purity (Figure 3B) and cloned. Again, gesting that the daughters of progenitor cells exhibit a
the cloning efficiency was high (31%; Table 3). All the very high potential to express Ly49G2 as they differenti-
clones homogeneously expressed Ly49G2. Strikingly, ate in the absence of MHC ligands. In contrast, 70% of
27% of the colonies contained Ly49C/I1 cells, typically clones that developed on H-2d stromal cells contained
on a fraction of the cells. However, none of the clones few or no Ly49G21 NK cells (Figure 4C). Thus, expres-
expressed Ly49A or Ly49F. These data suggest that sion of a strong MHC ligand for the Ly49A transgene
Ly49 receptors are expressed successively but that the (H-2Dd) resulted in a reduced likelihood of Ly49G2 ex-
potential to initiate expression of certain Ly49 receptors pression. Again, an intermediate result was obtained
is lost in an orderly fashion as development proceeds. when the stromal cells expressed H-2b (Figure 4C; 23%),
and little or no effect could be attributed to MHC expres-
Influence of Stromal Class I MHC on Cumulative sion by the cloned NK cells themselves (compare Figure
Ly49 Expression Potential 4C versus Figure 4D). Thus, in the clonogenic assay,
We next tested the effect of stromal class I MHC expres- the MHC haplotype of the stromal cells critically influ-
sion on the successive expression of Ly49 receptors in ences the cumulative potential for Ly49 receptor expres-
the clonogenic assay. We used precursors from Ly49A sion during NK cell differentiation.
transgenic mice and analyzed subsequent expression We next examined whether the levels of Ly49 surface
of the Ly49G2 receptor during differentiation in vitro. expression were also modulated by MHC ligand (Figures
Both of these receptors are reactive with H-2d ligands. 4E and 4F). When Ly49Atgb2m2/2 precursors were used,
The Ly49A transgene is driven by a class I promoter and Ly49G2 mean fluorescence intensity (MFI) values were
significantly higher on b2m2/2 stroma (Figure 4E; 76 6Ig enhancer and is expressed by all NK cells in vivo.
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17) than on B6 stroma (37 6 5) or B10.D2 stroma (17 6
2). In contrast, no significant differences in MFI were
observed when Ly49AtgB10.D2 precursors were used
(compare Figure 4E versus Figure 4F). Whether this re-
flects the lower number of clones analyzed or an influ-
ence of the endogenous H-2Dd ligand is unclear. None-
theless, the trend in Figure 4E demonstrates that the
MHC haplotype of the bone marrow stromal cells also
plays an important role in determining the levels of Ly49
receptor expression. Interestingly, the same trend was
seen with respect to surface expression levels of both
the endogenous Ly49G2 receptor (Figures 4E and 4F)
and the transgenic Ly49A receptor (data not shown).
Discussion
Proliferation and Ly49 Expression under Defined
Clonal Conditions
The results demonstrate that a mixture of cytokines and
irradiated stromal cells supports clonal growth and dif-
ferentiation of NK cells, starting with either NK1.11
DX51Ly492 bone marrow cells or c-kit1Sca-21Lin2 bone
marrow cells. The NK1.11 precursor cells yielded only
NK cell clones, while the c-kit1Sca-21Lin2 population
yielded clonal populations containing either NK cells, B
lineage cells, or both. The c-kit1Sca-21Lin2 population
has been previously shown to exhibit potential for NK
and B lineage development in vitro (Williams et al., 1997)
but is devoid of pluripotent stem cells (Antica et al.,
1994). The absence of T lineage differentiation by these
cells in the in vitro system is likely to reflect the absence
of thymic tissue to support T cell development.
Significantly, our results indicate that stromal cells
participate in supporting the proliferation or survival of
developing NK cells. Efficient clonal growth in our sys-
tem required the presence of stromal cells. In a previous
study, the same cytokines we employed, in the absence
of stromal cells, were able to support the proliferation
of developing NK cells cultured at high cell densities
(Williams et al., 1997). It is possible that the high cell
density cultures contain contaminating stromal cells or
that, at high cell density, NK cells can provide them-
Figure 4. Influence of Stromal Class I MHC on the Cumulative Ex-
selves with signals necessary for sustained cell growth.pression of Ly49G2 on Clonally Differentiating Ly49Atg c-kit1Sca-
Importantly, the clonogenic culture system supported21Lin2 Precursors
the initiation of expression of various Ly49 receptors on(A and B) The percentage of NK cells expressing Ly49G2 in each
developing NK cell populations. Ly49 receptor expres-colony from Ly49Atg multipotent precursors that differentiated on
class I MHC-different stromal cells are indicated. Bone marrow pre- sion occurred using either NK1.11DX51Ly492 bone mar-
cursors (Ly49Atgc-kit1Sca-21Lin2) were sorted and cloned onto irra- row cells or c-kit1Sca-21Lin2 cells as precursor cells.
diated bone marrow stromal cells derived from B6 (H-2b), B10.D2 It is striking that the same cytokines we used failed to
(H-2d), and b2m2/2 mice. Colonies were analyzed for Ly49G2 expres- support the initiation of Ly49 expression in high-density
sion (on NK1.11 cells) by flow cytometry. Each circle represents
NK cell cultures lacking stromal cells (Williams et al.,one colony; the mean percentages (thick bars) 6 SEM are shown.
1997). However, more recent studies in the same systemStatistical significance values based on the two-tailed Student's t
demonstrated Ly49 receptor expression in bulk culturestest are indicated. The dotted line represents the #5% threshold
used for plotting (C) and (D). in the presence of OP9 stromal cells (Williams et al.,
(C and D) The frequency of Ly49Atg clones that generated #5% 1999). In our studies, both primary bone marrow±derived
Ly49G21 NK cells per colony (see [A] and [B], dotted line) are indi- stromal cells and the OP9 stromal cell line supported
cated for clones derived on each type of stroma. Statistical signifi- the initiation of Ly49 receptor expression, and the spec-
cance values based on the two-tailed chi-square (x2) test are indi-
trum of Ly49 receptor expression observed was similarcated.
with both types of stromal cells. Together, the data imply(E and F) The levels of Ly49G2 surface expression are indicated for
that stromal cells provide the signal(s) necessary forclones derived on each type of stroma. Colonies were analyzed for
the mean fluorescence intensities (MFI 6 SEM) of Ly49G2 expres- both initiation of Ly49 expression and efficient clonal
sion (on NK1.11Ly49G21 cells). Statistical significance values based growth.
on the two-tailed Student's t test are indicated. Interestingly, if a given Ly49 receptor was not de-
tected in a colony on the first day tested, typically day
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10 of culture, it was also not observed later, even at the pathway. In contrast, Ly49G21A/C/F/I2 NK cells
were able to initiate Ly49C/I1 expression but not Ly49Aday 30 of the culture (data not shown). These findings
or Ly49F expression. The results suggest that the poten-suggest that initiation of Ly49 expression probably does
tial to initiate Ly49A expression is lost early. After cellsnot occur continuously throughout the culture period,
have initiated Ly49G2 expression, the capacity to initiatebut may be restricted to an early phase. Whether this
expression of Ly49F is also lost, while the potential tois a limitation of the in vitro system or reflects a true
initiate Ly49C/I expression is maintained. In recentlylimitation in the progenitor cells is uncertain.
reported bulk culture experiments, Ly49A expression
was detected after Ly49G2 and Ly49C/I (and/or Ly49H)Developmental Restrictions in the Initiation
on developing NK cells (Williams et al., 1999). However,of Ly49 Expression
our clonal analysis of sorted Ly49G21A/C/F/I2 cells didTwo aspects of our current data fit with the previously
not yield any Ly49A1 progeny, even though Ly49A ex-proposed ªsequential expression modelº of NK cell de-
pression was shown to be quite stable once initiated.velopment, which proposed that NK cells sequentially
Our results support the notion that Ly49 receptor ex-accumulate Ly49 receptors until receptors specific for
pression potential becomes increasingly restricted asself MHC class I molecules are expressed, at which time
NK cells develop.the accumulation of new receptors is inhibited (albeit
A possible model to explain the data is that the initia-incompletely) (Held and Raulet, 1997; Raulet et al., 1997).
tion of receptor expression occurs with a strict sequenceFirst, essentially all clones derived from Ly49A1 or
in development, reflecting sequential waves of potentialLy49G21 NK cells stably maintained expression of the
to express different receptors. Alternatively, there maycorresponding receptor, consistent with previous in vivo
be no specific preferred sequence of receptor initiation,data (Dorfman and Raulet, 1998). Second, we directly
but rather a process in which receptor genes becomedemonstrated that cells expressing Ly49A or Ly49G2
sequentially unavailable for de novo initiation. In thecan subsequently initiate expression of a second recep-
latter scheme, the earliest cells would have the potentialtor under clonal conditions.
to express all receptors with approximately equal likeli-An exciting aspect of our results is the finding that
hood, while later cells would be more restricted withinput progenitor populations vary considerably in their
respect to which receptors can be initiated. We have nopotential to initiate expression of different Ly49 recep-
information as to the molecular mechanisms underlyingtors. For example, the NK1.11DX51Ly492 precursor
successively restricted Ly49 expression, though genepopulation exhibited potential to initiate expression of
order on the chromosome must be considered a possi-Ly49G2 and Ly49C/I receptors, but little or no potential
bility (Dillon and Grosveld, 1993).to initiate expression of Ly49A or Ly49F. Two observa-
tions indicate that the limited potential of these cells to
Implications of the Results for the Product Ruleexpress different Ly49 receptors is not an artifactual
We have previously pointed out that the frequency of NKlimitation of the culture system. First, the in vitro culture
cells expressing a given combination of Ly49 receptorssystem supported the initiation of expression of all Ly49
approximately equals the product of the frequencies ofreceptors tested when c-kit1Sca-21Lin2 progenitor cells
cells in the total population expressing each receptor
were employed. Second, the in vitro results with bone
(ªthe product ruleº) and suggested on this basis that
marrow NK1.11CD32Ly492 precursor cells mirror our
receptor gene expression is initiated randomly in NK cell
previous in vivo findings, in which splenic NK1.11Ly492 progenitors (Raulet et al., 1997). While our new results
precursor cells, when transferred to sublethally irradi- suggest temporal restrictions on Ly49 receptor initia-
ated mice, were capable of initiating expression of tion, they do not contradict the proposal that the recep-
Ly49G2 and Ly49C/I but were incapable of initiating tor initiation pattern in individual NK cells is a stochastic
expression of Ly49A (Ly49F was not tested) (Dorfman process. We propose that at an early stage where ex-
and Raulet, 1998). Indeed, the present data with bone pression of one Ly49 receptor is allowed, only a fraction
marrow populations argue that the earlier in vivo result of the cells actually succeed in initiating expression.
did not reflect a limitation of splenic NK cells as com- Stochastic initiation of a different receptor at a later
pared to bone marrow NK cells, a possibility we had stage can occur in some cells that do express the earlier
previously considered (Dorfman and Raulet, 1998). receptor and in some cells that do not. Thus, expression
The simplest interpretation of the different results with of different receptors may be displaced in time yet still
NK1.11DX51Ly492 and c-kit1Sca-21Lin2 precursor pop- be independent and stochastic. Such a process would
ulations is that the potential to express different Ly49 be expected to yield receptor expression frequencies
receptors changes with the developmental stage. In this fully consistent with the product rule.
model, the potential to initiate Ly49A expression is di- Despite the indications that expression of different
minished once a developing precursor cell expresses Ly49 receptors often occurs independently, in one in-
NK1.1, but the potential to initiate expression of Ly49G2 stance we observed a possible deviation from this pat-
and Ly49C/I is maintained. tern. Initiation of Ly49F expression occurred at a high
The notion that the potential to express different Ly49 frequency (approximately 50%) in colonies derived from
receptors becomes successively restricted during de- Ly49A1Ly49C/F/G2/I2 precursor cells, despite the fact
velopment was strongly supported by the clonal analysis that Ly49F is expressed by only approximately 12%
of NK cells sorted to express only Ly49A or only Ly49G2. of all NK cells in normal B6 mice. Initiation of Ly49F
Ly49A1C/F/G2/I2 NK cells gave rise to colonies con- expression does not depend on previous initiation of
taining Ly49C/I1, Ly49F1, and Ly49G21 cells, as might Ly49A expression, however, since approximately two-
thirds of Ly49F1 NK cells in normal mice do not expressbe expected for a receptor that is expressed early in
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Ly49A (T. Hanke, H. T., and D. H. R., unpublished data). number of Ly49A1G21 cells, as previously noted, but to
an increased number of Ly49A1G22 cells. As predicted,Nevertheless, the data suggest that expression of Ly49F
is not wholly independent of expression of Ly49A, per- we previously observed an increased percentage of
Ly49A1G22 NK cells in B10.D2 mice compared to B6 orhaps indicating commonalities in the regulation of the
Ly49f and Ly49a genes. B6-b2m2/2 mice (Held et al., 1996). On the other hand, if
Ly49G2 expression can only be initiated after expression
of Ly49A, we would not expect to observe a similarRegulation of Inhibitory Ly49 Receptor Expression
increase in Ly49G21A2 NK cells. Again, the previousby Stromal Class I MHC
data fit with this prediction, because the percentage ofOur results demonstrate a significant effect of stromal
Ly49G21A2 NK cells did not differ in B10.D2 mice asclass I MHC expression in determining the sequential
compared to B6 and B6-b2m2/2 mice (Held et al., 1996).expression of inhibitory Ly49 receptors by clonally dif-
The Ly49G21A2 NK cells were presumably derived fromferentiating NK cells. Importantly, the in vitro assay fully
cells that failed to express Ly49A at the earlier stagerecapitulates previous in vivo studies (Held and Raulet,
and were, therefore, not influenced by expression of1997; Raulet et al., 1997), showing that transgenic expres-
Ly49A ligands. As indicated by this example, an orderedsion of Ly49A results in reduced numbers of Ly49G21
sequence of Ly49 receptor expression is expected toNK cells in H-2d mice, has less effect in H-2b mice, and
impact the final repertoire considerably.has no effect in class I±deficient mice. As noted pre-
Finally, we note that MHC molecules from both theviously, the intermediate results obtained with H-2b stro-
stromal and the hematopoietic cells in the cultures re-mal cells suggest that Ly49A interacts weakly with H-2b
duce the cell surface expression levels of Ly49G2 andclass I molecules, sufficient to observe developmental
Ly49A. Previous studies have shown that the MHC-effects but insufficient to inhibit NK cell effector activity
dependent reduction in Ly49A cell surface expression lev-(Held and Raulet, 1997). The results with the in vitro
els is a posttranscriptional event and may reflect ligand-clonal assay go beyond the in vivo studies by demon-
induced receptor modulation (Held and Raulet, 1997).strating that MHC expression influences both the pro-
portion of clones that contain Ly49G21 cells and the
average percentage of Ly49G21 cells found within each Concluding Remarks
clone. The results are consistent with the notion that The clonogenic assay presented here furnishes evi-
engagement of class I ligands by Ly49A reduces the dence that bone marrow stromal cells provide signals
likelihood per unit time that the developing NK cell will necessary for efficient clonal growth of NK cells, as well
initiate expression of Ly49G2. Thus, fewer clones will as for initiation of Ly49 expression. Further studies will
ultimately contain cells expressing Ly49G2, and those be necessary to define the nature of these signals, which
that do may tend to initiate expression later in the clonal could be cytokine(s) and/or cell±surface counterrecep-
expansion phase. Alternatively, MHC expression may tors. An interesting possibility is that stromal cells pro-
impact the rate of proliferation or death of Ly49G21 cells vide stimulatory signals to developing NK cells akin to
that arise in each clone. The in vitro system should be the signals that activate NK cell lytic activity. Activation
advantageous in discriminating these possibilities. of stimulatory receptors on developing NK cells may
An equally significant conclusion is that the effects of be necessary to initiate the Ly49 receptor expression
class I MHC expression in the in vitro system are medi- program. Obviously, the in vitro system can be employed
ated primarily by stromal cell MHC molecules, rather as an assay to identify the relevant signals. Since the
than by MHC molecules on the NK cells themselves. A genotype of the stroma and progenitor can be varied
caveat is that these clonal cultures contain a low density independently of each other, the system also holds
of hematopoieitic cells for the first week of culture, which promise for dissecting the genetic mechanisms respon-
may minimize NK cell±hematopoieitic cell interactions. sible for shaping the repertoire of developing NK cells.
In this respect, we cannot rule out that additional MHC Such an analysis will require extensive examination of
effects may occur at the high cell densities that occur the effects of genetic mutations on the developing reper-
in vivo. Nevertheless, the results suggest minimally that toire in the context of varying the MHC molecules ex-
repertoire formation is primarily determined by interac- pressed by stromal cells and NK progenitors.
tions in trans between Ly49 receptors on precursor cells
and MHC ligands expressed by other cells (stromal or
Experimental Procedureshematopoietic), rather than through cis interactions of
Ly49 receptors and MHC ligands on the same cell. Such
Animals
cell-autonomous interactions were suggested by the C57Bl/6NCR (B6, H-2b), B10.D2 (H-2d), and B6-b2m2/2 mice were
X-ray crystal structure of Ly49A complexed with H-2Dd, bred in the animal facility of the University of California (Berkeley,
CA) and used at 7-12 weeks of age. Congenic B6-Ly5.1 mice werewhich raised the possibility that Ly49A and Dd may inter-
purchased from the National Cancer Institutes (Frederick, MD),act in the same plasma membrane (Tormo et al., 1999).
where they are listed as B6-Ly5.2 according to the previous nomen-It is interesting to consider the implications of the
clature. Ly49A transgenic mice on the B10.D2 and B6-b2m2/2 back-collective results for the development of the repertoire
ground were described (Held and Raulet, 1997).
of Ly49 receptors, especially if Ly49 receptor expression
is initiated in a defined order. Consider the early devel-
Antibodies and Stainingoping NK cells in H-2d mice that have just initiated ex-
The following mAbs and reagents were used: JR9±318 (anti-Ly49A;
pression of Ly49A. Engagement of Dd by Ly49A should kindly provided by J. Roland), HBF-719 (anti-Ly49F; H. T., unpub-
decrease the probability of subsequent Ly49G2 expres- lished data), 4D11 (anti-Ly49G2 [Mason et al., 1995]), and SW5E6
(anti-Ly49C/I; generously provided by Drs Vinay Kumar and Michaelsion. This effect should lead not only to a decreased
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